These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 19965947)

  • 1. Prophylactic antivirals may be helpful in prevention of varicella-zoster virus reactivation in myeloma, but are they safe?
    Dasanu CA; Alexandrescu DT
    J Oncol Pharm Pract; 2010 Dec; 16(4):266-8. PubMed ID: 19965947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acyclovir to prevent reactivation of varicella zoster virus (herpes zoster) in multiple myeloma patients receiving bortezomib therapy.
    Vickrey E; Allen S; Mehta J; Singhal S
    Cancer; 2009 Jan; 115(1):229-32. PubMed ID: 19090004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acyclovir prophylaxis against varicella zoster virus reactivation in multiple myeloma patients treated with bortezomib-based therapies: a retrospective analysis of 100 patients.
    Swaika A; Paulus A; Miller KC; Sher T; Almyroudis NG; Ball D; Wood M; Masood A; Lee K; Chanan-Khan AA
    J Support Oncol; 2012; 10(4):155-9. PubMed ID: 22222250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daily 500 mg valacyclovir is effective for prevention of Varicella zoster virus reactivation in patients with multiple myeloma treated with bortezomib.
    Fukushima T; Sato T; Nakamura T; Iwao H; Nakajima A; Miki M; Sakai T; Kawanami T; Sawaki T; Fujita Y; Tanaka M; Masaki Y; Okazaki T; Nakajima H; Motoo Y; Umehara H
    Anticancer Res; 2012 Dec; 32(12):5437-40. PubMed ID: 23225448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Varicella-zoster virus prophylaxis with low-dose acyclovir in patients with multiple myeloma treated with bortezomib.
    Pour L; Adam Z; Buresova L; Krejci M; Krivanova A; Sandecka V; Zahradova L; Buchler T; Vorlicek J; Hajek R
    Clin Lymphoma Myeloma; 2009 Apr; 9(2):151-3. PubMed ID: 19406726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bortezomib and bilateral herpes zoster.
    di Meo N; Bergamo S; Dondas A; Trevisan G
    Acta Dermatovenerol Alp Pannonica Adriat; 2012; 21(1):21-2. PubMed ID: 22584902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose acyclovir is effective for prevention of herpes zoster in myeloma patients treated with bortezomib: a report from the Korean Multiple Myeloma Working Party (KMMWP) Retrospective Study.
    Kim SJ; Kim K; Do YR; Bae SH; Yang DH; Lee JJ
    Jpn J Clin Oncol; 2011 Mar; 41(3):353-7. PubMed ID: 20947927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of continuous, daily, oral, ultra-low-dose 200 mg acyclovir to prevent herpes zoster events among bortezomib-treated patients: a report from retrospective study.
    Aoki T; Nishiyama T; Imahashi N; Kitamura K
    Jpn J Clin Oncol; 2011 Jul; 41(7):876-81. PubMed ID: 21616919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation.
    Kanda Y; Mineishi S; Saito T; Saito A; Yamada S; Ohnishi M; Chizuka A; Niiya H; Suenaga K; Nakai K; Takeuchi T; Makimoto A; Tanosaki R; Kami M; Tanaka Y; Fujita S; Watanabe T; Kobayashi Y; Tobinai K; Takaue Y
    Bone Marrow Transplant; 2001 Oct; 28(7):689-92. PubMed ID: 11704792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence, risk factors, and implemented prophylaxis of varicella zoster virus infection, including complicated varicella zoster virus and herpes simplex virus infections, in lenalidomide-treated multiple myeloma patients.
    König C; Kleber M; Reinhardt H; Knop S; Wäsch R; Engelhardt M
    Ann Hematol; 2014 Mar; 93(3):479-84. PubMed ID: 24318541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Varicella-zoster virus prophylaxis with the traditional Chinese medicine Radix isatidis (Banlangen) in patients with multiple myeloma treated with bortezomib.
    Guo H; Mao J; Qian X; Sun C; Sun H
    J Altern Complement Med; 2011 Nov; 17(11):985-6. PubMed ID: 22087609
    [No Abstract]   [Full Text] [Related]  

  • 12. Analysis of herpes zoster events among bortezomib-treated patients in the phase III APEX study.
    Chanan-Khan A; Sonneveld P; Schuster MW; Stadtmauer EA; Facon T; Harousseau JL; Ben-Yehuda D; Lonial S; Goldschmidt H; Reece D; Neuwirth R; Anderson KC; Richardson PG
    J Clin Oncol; 2008 Oct; 26(29):4784-90. PubMed ID: 18711175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late onset of bortezomib-associated cutaneous reaction following herpes zoster.
    Varettoni M; Vassallo C; Borroni G; Mangiacavalli S; Zappasodi P; Rosso R; Lazzarino M; Corso A
    Ann Hematol; 2007 Apr; 86(4):301-2. PubMed ID: 17131123
    [No Abstract]   [Full Text] [Related]  

  • 14. Decrease in CD4+ T-cell counts in patients with multiple myeloma treated with bortezomib.
    Heider U; Rademacher J; Kaiser M; Kleeberg L; von Metzler I; Sezer O
    Clin Lymphoma Myeloma Leuk; 2010 Apr; 10(2):134-7. PubMed ID: 20371447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The high incidence of varicella herpes zoster with the use of bortezomib in 10 patients.
    Tong Y; Qian J; Li Y; Meng H; Jin J
    Am J Hematol; 2007 May; 82(5):403-4. PubMed ID: 17133426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does bortezomib induce de facto varicella zoster virus reactivation in patients with multiple myeloma?
    Dasanu CA; Alexandrescu DT
    J Clin Oncol; 2009 May; 27(13):2293-4; author reply 2294-6. PubMed ID: 19307496
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term ultra-low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation.
    Asano-Mori Y; Kanda Y; Oshima K; Kako S; Shinohara A; Nakasone H; Sato H; Watanabe T; Hosoya N; Izutsu K; Asai T; Hangaishi A; Motokura T; Chiba S; Kurokawa M
    Am J Hematol; 2008 Jun; 83(6):472-6. PubMed ID: 18266207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose acyclovir prophylaxis for bortezomib-induced herpes zoster in multiple myeloma patients.
    Minarik J; Pika T; Bacovsky J; Langova K; Scudla V
    Br J Haematol; 2012 Oct; 159(1):111-3. PubMed ID: 22816982
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug-induced hypersensitivity syndrome after bortezomib treatment for refractory multiple myeloma.
    Hattori N; Adachi D; Nakashima H; Saito B; Nakamaki T; Tomoyasu S
    Leuk Res; 2009 Apr; 33(4):574-7. PubMed ID: 18838167
    [No Abstract]   [Full Text] [Related]  

  • 20. Low-dose acyclovir against reactivation of varicella zoster virus after unrelated cord blood transplantation.
    Uchiyama M; Tamai Y; Ikeda T
    Int J Infect Dis; 2010 May; 14(5):e451-2. PubMed ID: 19692277
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.